Compounds and compositions for treating conditions associated with sting activity
US-2024308978-A1 · Sep 19, 2024 · US
Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D209/40 |
| Official title | Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone |
| Display label | Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone |
| Total patents | 181 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 21 |
| 2016 | 16 |
| 2017 | 26 |
| 2018 | 26 |
| 2019 | 23 |
| 2020 | 18 |
| 2021 | 10 |
| 2022 | 13 |
| 2023 | 9 |
| 2024 | 13 |
| 2025 | 6 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Polymerizable compound and optically anisotropic object
US-2017369783-A1 · Dec 28, 2017 · US
Compounds and methods for inhibiting fascin
US-9850243-B2 · Dec 26, 2017 · US
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
US-9796741-B2 · Oct 24, 2017 · US
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
US-2017298085-A1 · Oct 19, 2017 · US
Amide compounds for treatment of complement mediated disorders
US-2017298084-A1 · Oct 19, 2017 · US
Polymerizable compound, composition, polymer, optically anisotropic body, liquid crystal display element, and organic el device
US-2017260150-A1 · Sep 14, 2017 · US
Phosphonate compounds for treatment of complement mediated disorders
US-2017260219-A1 · Sep 14, 2017 · US
Hydrazone modulators of cannabinoid receptors
US-2017231953-A1 · Aug 17, 2017 · US
Ether compounds for treatment of complement mediated disorders
US-9732104-B2 · Aug 15, 2017 · US
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
US-9732103-B2 · Aug 15, 2017 · US
Factor D Inhibitors Useful for Treating Inflammatory Disorders
US-2017226142-A1 · Aug 10, 2017 · US
Amino Compounds for Treatment of Complement Mediated Disorders
US-2017189410-A1 · Jul 6, 2017 · US
Amide compounds for treatment of complement mediated disorders
US-9695205-B2 · Jul 4, 2017 · US
Isoxazole treatments for frontotemporal dementia
US-2017172987-A1 · Jun 22, 2017 · US
Phosphonate compounds for treatment of complement mediated disorders
US-9663543-B2 · May 30, 2017 · US
Hydrazone modulators of cannabinoid receptors
US-9656957-B2 · May 23, 2017 · US
Factor D inhibitors useful for treating inflammatory disorders
US-9643986-B2 · May 9, 2017 · US
Indolyl or indolinyl hydroxamate compounds
US-9598364-B2 · Mar 21, 2017 · US
SMYD2 inhibitors
US-9598381-B2 · Mar 21, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D209/40?
- CPC C07D209/40 is the Cooperative Patent Classification code for “Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone.”
- How many patents are filed under CPC C07D209/40 (Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone)?
- Our database includes 181 publications tagged with this CPC code.
- Is patent activity under CPC C07D209/40 growing?
- Publication counts under this code: 13 in 2024 vs 6 in 2025 (latest complete years).